Cheelcare to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
Markham, Ontario--(Newsfile Corp. - April 14, 2026) - Cheelcare Inc. (TSXV: CHER) (OTC: CHCRF) ("Cheelcare" or the "Company"), a Canadian innovator in advanced mobility solutions, announced today that it will participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference take place April 21-22, 2026, at the Metro Toronto Convention Centre in Toronto, Canada. Cheelcare's CEO, Eugene Cherny and VP of Growth, Allan Boyd will present and participate in one-on-one meetings with...
2026-04-14 7:30 AM EDT
WELL Health and WELLSTAR to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference
Vancouver, British Columbia--(Newsfile Corp. - April 13, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, and its majority-owned subsidiary WELLSTAR Technologies Corp. ("WELLSTAR"), Canada's leading provider of connected technology solutions for healthcare providers, are pleased to...
2026-04-13 7:30 AM EDT
ProMIS Neurosciences Invited to Participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Cambridge, Massachusetts--(Newsfile Corp. - April 13, 2026) - ProMIS Neurosciences, Inc. (NASDAQ: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease (AD) and other neurodegenerative disorders, today announced that Neil Warma, Chief Executive Officer, will participate in the 2026 Bloom Burton & Co. Healthcare Investor Conference. The conference is being held April 21-22, 2026, at the Metro Toronto Convention Centre in Toronto, Ontario....
2026-04-13 7:30 AM EDT
HEALWELL to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 13, 2026) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare artificial intelligence company focused on preventative care, is pleased to announce that the Company will be participating as a presenting company at the 2026 Bloom Burton & Co. Healthcare Investor Conference. James Lee, CEO and Dr. Alexander Dobranowski, President, will be attending and hosting one-on-one meetings with investors throughout the...
2026-04-13 7:00 AM EDT
AtomVie Global Radiopharma to Present at The Bloom Burton & Co. Healthcare Investor Conference 2026
Hamilton, Ontario--(Newsfile Corp. - April 9, 2026) - AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in GMP manufacturing for clinical and commercial supply of radiopharmaceuticals and their worldwide distribution, is pleased to announce that they will be presenting at the Bloom Burton & Co. Healthcare Investor Conference (BBHIC) 2026, taking place at the Metro Convention Centre in Toronto,...
2026-04-09 10:00 AM EDT
Conavi Medical to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) ("Conavi" or the "Company"), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that Thomas Looby, CEO of Conavi Medical, will present and participate in one-on-one meetings at the 2026 Bloom Burton & Co. Healthcare Investor Conference to be held April...
2026-04-09 7:00 AM EDT
Custom Health to Participate in Upcoming 2026 Bloom Burton & Co. Healthcare Investor Conference
Kelowna, British Columbia--(Newsfile Corp. - April 8, 2026) - Custom Health Inc. ("Custom Health" or the "Company"), a vertically integrated, tech-enabled care platform, is pleased to announce that the Company will be participating as a presenting company at the 2026 Bloom Burton & Co. Healthcare Investor Conference. Shane Bishop, Chief Executive Officer, will be presenting and will also be hosting one-on-one meetings with investors throughout the conference. 2026 Bloom Burton & Co....
2026-04-08 2:10 PM EDT
Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Spectral Medical Inc. (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, will be participating in the 2026 Bloom Burton & Co. Healthcare Investor Conference, which will take place on April 21 and 22 at the Metro Toronto Convention Centre. Dates: Tuesday April 21, 20
2026-04-01 7:30 AM EDT
Bloom Burton & Co. Announces the 2026 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - February 4, 2026) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce the launch of the 2026 Bloom Burton Award and to open nomination submissions from the public at large on or before March 27, 2026. The finalists for the 2026 Bloom Burton Award will be announced at the 2026 Bloom Burton & Co. Healthcare Investor Conference, taking place at the Metro Toronto Convention Centre from April 21-22, 2026.
2026-02-04 8:25 AM EST
Oliver Technow Receives the 2025 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - September 26, 2025) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce Oliver Technow, former Chief Executive Officer of BIOVECTRA, as the recipient of the 2025 Bloom Burton Award. 2025 Bloom Burton Award Winner Oliver Technow, former Chief Executive Officer of BIOVECTRA To view an enhan
2025-09-26 7:36 AM EDT
Bloom Burton & Co. Inc. Announces Exercise of Satellos Bioscience Inc. Warrants
Toronto, Ontario--(Newsfile Corp. - May 20, 2025) - Bloom Burton & Co. Inc. (Bloom Burton) announces that, today, it exercised 3,200,000 common share purchase warrants (Warrants) of Satellos Bioscience Inc. (Corporation) at $0.50 per share for aggregate consideration of $1,600,000, and the remaining 3,360,474 unexercised Warrants expired. This resulted in a decrease of beneficial holdings to under 10%, requiring the filing of an early warning report in connection therewith. Prior to this...
2025-05-20 7:01 PM EDT
Three Finalists Announced for the 2025 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - May 14, 2025) - Bloom Burton & Co. is pleased to announce the finalists for the 2025 Bloom Burton Award. Bestowed annually and nominated by the public at large, the Bloom Burton Award honours an individual who made the greatest contribution to Canada's innovative healthcare industry in the previous year. The finalists for 2025, in alphabetical order, are: Mark Nawacki, former President and Chief Executive Officer, Searchlight Pharma Oliver Technow, former...
2025-05-14 7:00 AM EDT
Orpyx Medical Technologies Inc. to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
Calgary, Alberta--(Newsfile Corp. - May 2, 2025) - Orpyx® Medical Technologies Inc. ("Orpyx"), a leader in digital health solutions for the prevention of diabetic foot complications, today announced that Justine Jones, Senior Vice President, Commercial, will present at the 2025 Bloom Burton & Co. Healthcare Investor Conference held at the Metro Toronto Convention Centre. Ms. Jones will deliver an overview of Orpyx's innovative technologies and commercial strategy on Tuesday, May 6, 2025, at...
2025-05-02 10:08 AM EDT
Entos Pharmaceuticals (Entos) Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference
Edmonton, Alberta--(Newsfile Corp. - May 1, 2025) - Entos Pharmaceuticals (Entos), a clinical-stage genetic medicines company headquartered in Edmonton, Canada, with offices in London, UK, and San Diego, USA, will be participating in the 2025 Bloom Burton & Co. Healthcare Investor Conference, which will take place on May 5 and 6 at the Metro Toronto Convention Centre. Dates: Monday May 5, 2025 - Tuesday May 6, 2025
2025-05-01 8:30 AM EDT
Altis Labs, Inc. Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - Altis Labs, Inc., the computational imaging company accelerating clinical trials with AI, will be participating in the 2025 Bloom Burton & Co. Healthcare Investor Conference, which will take place on May 5 and 6 at the Metro Toronto Convention Centre. Dates:Monday May 5, 2025 - Tuesday May 6, 2025 Time:
2025-04-30 9:00 AM EDT
Conavi Medical to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 25, 2025) - Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) ("Conavi" or the "Company"), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that Thomas Looby, CEO of Conavi Medical, will present and participate in one-on-one meetings at the 2025 Bloom Burton & Co. Healthcare Investor Conference being held in...
2025-04-25 7:00 AM EDT
Specialty Medical Partners Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 15, 2025) - Specialty Medical Partners, We aim to establish Canada’s most comprehensive outpatient specialty medical group, integrating all aspects of non-hospital-based specialty care., will be participating in the 2025 Bloom Burton & Co. Healthcare Investor Conference, which will take place on May 5 and 6 at the Metro Toronto Convention Centre. Dates: Monday May 5, 2025 - Tuesday May 6, 2025Time:
2025-04-15 9:22 AM EDT
PharmaCorp Rx Inc. Announces Participation in the 2025 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 14, 2025) - PharmaCorp Rx Inc. (TSXV: PCRX) will be participating in the 2025 Bloom Burton & Co. Healthcare Investor Conference, which will take place on May 5 and 6 at the Metro Toronto Convention Centre. Dates: Monday May 5, 2025 - Tuesday May 6, 2025 Time:8:30 AM - 5:00 PM ET
2025-04-14 7:30 AM EDT
Bloom Burton & Co. Announces the 2025 Bloom Burton Award
Toronto, Ontario--(Newsfile Corp. - January 29, 2025) - Bloom Burton & Co. ("Bloom Burton") is pleased to announce the launch of the 2025 Bloom Burton Award and to open nomination submissions from the public at large on or before March 31, 2025. The finalists for the 2025 Bloom Burton Award will be announced at the 2025 Bloom Burton & Co. Healthcare Investor Conference, taking place at the Metro Toronto Convention Centre from May 5-6, 2025.
2025-01-29 7:00 AM EST
Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.
Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton) announces that, today, it acquired 1,692,250 common shares (Shares) of Satellos Bioscience Inc. (Corporation) in connection with a public offering of the Corporation by way of a prospectus supplement dated December 17, 2024 to the short form prospectus dated April 7, 2024. Bloom Burton purchased the Shares at a price of $0.90 per Share for total consideration of $1,523,025. Combined with former...
2024-12-20 5:03 PM EST